Reprogramming Gastric Cancer Therapy: A Microbiome-Guided Approach to Precision Oncology
Current Microbiology · 2026
DOI: 10.1007/s00284-026-04723-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Microbiology, 2026. Verfasst von Pourya Gholizadeh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Zoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran. poorya.gholizadeh@gmail.com. Hauptthemen laut MEDLINE: Stomach Neoplasms, Precision Medicine, Gastrointestinal Microbiome. Die Arbeit nennt 98 Literaturangaben.
Abstract (Originalsprache)
Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide, with limited therapeutic success in advanced stages. Emerging evidence suggests that the gut microbiota plays a pivotal role in modulating tumor progression, immune responses, and treatment efficacy. This review explores the multifaceted interactions between the gut microbiome and GC therapies, including surgery, chemotherapy, radiotherapy, immunotherapy, and viroimmunotherapy. We highlight how microbial dysbiosis influences treatment outcomes and discuss the potential of microbiota-targeted interventions such as probiotics, prebiotics, fecal microbiota transplantation (FMT), and microbial metabolites to enhance therapeutic efficacy and reduce adverse effects. Furthermore, we examine clinical and preclinical studies that support the integration of microbiome modulation into personalized cancer care. Harnessing the gut microbiota as a therapeutic offers a promising avenue for improving GC management. Future strategies should focus on microbiome-informed treatment design to optimize clinical outcomes and pave the way for precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Zoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran. poorya.gholizadeh@gmail.com.
- Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran. poorya.gholizadeh@gmail.com.
- Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran. elnaz.faghfuri@gmail.com.
Zitieren
APA
Gholizadeh, P., & Faghfuri, E. (2026). Reprogramming Gastric Cancer Therapy: A Microbiome-Guided Approach to Precision Oncology. Current Microbiology. https://doi.org/10.1007/s00284-026-04723-6
Vancouver
Gholizadeh P, Faghfuri E. Reprogramming Gastric Cancer Therapy: A Microbiome-Guided Approach to Precision Oncology. Current Microbiology. 2026. doi:10.1007/s00284-026-04723-6
BibTeX
@article{Gholizadeh2026,
author = {Gholizadeh, Pourya and Faghfuri, Elnaz},
title = {Reprogramming Gastric Cancer Therapy: A Microbiome-Guided Approach to Precision Oncology},
journal = {Current Microbiology},
year = {2026},
doi = {10.1007/s00284-026-04723-6}
}
EUVIMED